Ftse Mib
33.778,74
-1,51%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.144,68
-5,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Precipio Inc (PRPO) Precipio Inc (PRPO) Notizie

Precipio Inc

PRPO
5,7499
-0,1501 (-2,54%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:00:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/3/202422:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
13/2/202416:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
06/2/202416:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
23/1/202416:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
19/1/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202416:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
04/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202423:01EDGAR2Form 8-K - Current report
02/1/202415:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
14/12/202323:00EDGAR2Form 8-K - Current report
14/12/202322:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
16/11/202323:15EDGAR2Form 8-K - Current report
16/11/202323:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
13/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202321:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202315:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
06/10/202322:34EDGAR2Form 8-K - Current report
03/10/202316:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
28/9/202315:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
25/9/202317:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
21/9/202323:10EDGAR2Form 8-K - Current report
14/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
14/8/202322:00EDGAR2Form 8-K - Current report
11/8/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202323:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
08/8/202315:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
03/8/202315:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
01/8/202315:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
07/7/202322:30EDGAR2Form S-1 - General form for registration of securities under..
14/6/202315:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
13/6/202315:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
08/6/202314:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
07/6/202315:30GLOBEProjected cash burn reduced by $1.5 million annually from..
22/5/202317:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
17/5/202322:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
15/5/202322:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
04/5/202319:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
04/5/202316:00GLOBEPrecipio Signs Another HemeScreen™ Customer
Apertura: 5,91 Min: 5,61 Max: 6,079
Chiusura: 5,90

La tua Cronologia

NASDAQ
PRPO
Precipio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network